Page 203 - மருத்துவ+உதவி மோசடி கட்டுப்பாடு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மருத்துவ+உதவி மோசடி கட்டுப்பாடு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மருத்துவ+உதவி மோசடி கட்டுப்பாடு Today - Breaking & Trending Today

European Commission Grants Ocugen Orphan Medicinal Product Designation for Gene Therapy Product Candidate, OCU400, For the Treatment of Both Retinitis Pigmentosa and Leber Congenital Amaurosis


European Commission Grants Ocugen Orphan Medicinal Product Designation for Gene Therapy Product Candidate, OCU400, For the Treatment of Both Retinitis Pigmentosa and Leber Congenital Amaurosis
NR2E3), for the treatment of both retinitis pigmentosa (RP) and Leber Congenital amaurosis (LCA).
The prevalence of RP in Europe is estimated at approximately 165,000 patients and the prevalence of LCA in Europe is estimated at approximately 40,000 patients. Globally, the number of people suffering from RP and LCA is estimated to be around 2.0 million and 0.2 million, respectively.
We believe the granting of this designation by the European Commission validates the potential of our modifier gene therapy platform to treat many inherited retinal diseases, Chairman of the Board, Chief Executive Officer, and Co-founder of Ocugen. ....

United States , Neena Haider , Sanjay Subramanian , Emmie Twombly , Mohamed Genead , Professor Of Ophthalmology At Harvard Medical School , European Commission , Schepens Eye Research Institute , Ocugen Inc , Exchange Commission , Head Of Corporate Development , Nuclear Hormone Receptors , European Union , Leber Congenital , Chief Executive Officer , Retina Scientific Advisory Board , Acting Chief Medical Officer , Hormone Receptors , Associate Professor , Harvard Medical School , Associate Scientist , Massachusetts Eye , Bharat Biotech , Private Securities Litigation Reform Act , Financial Officer , Corporate Development ,

New report looks at uptake of telehealth in antenatal care during COVID-19 lockdowns


Date Time
New report looks at uptake of telehealth in antenatal care during COVID-19 lockdowns
Almost 1 in 10 antenatal services for March to September 2020 were delivered via telehealth according to a new report by the Australian Institute of Health and Welfare (AIHW).
The report, Antenatal care during COVID-19, 2020, includes information on antenatal care services, both face-to-face and telehealth, claimed through the Medicare Benefits Schedule (MBS). The report covers a range of private antenatal services and it does not include information on antenatal care provided by public hospitals.
‘These antenatal specific telehealth services were introduced in March 2020, to enable Australians to stay at home where possible to reduce the risk of COVID-19 transmission,’ said AIHW spokesperson Ms. Bernice Cropper. ....

Bernice Cropper , Australian Institute Of Health , National Perinatal Data Collection , Australian Institute , Medicare Benefits Schedule , South Australia , Covid 19 , பெர்னிஸ் பயிர் , ஆஸ்திரேலிய நிறுவனம் ஆஃப் ஆரோக்கியம் , தேசிய பெரிநாடல் தகவல்கள் சேகரிப்பு , ஆஸ்திரேலிய நிறுவனம் , மருத்துவ நன்மைகள் அட்டவணை , தெற்கு ஆஸ்திரேலியா ,

Regener Eyes: First-in-Class Biologic Eye Drop Regener-Eyes Announces New Clinical Advisory Board Member Dr. Art Epstein


(1)
PALM HARBOR, FL / ACCESSWIRE / February 23, 2021 / Regener-Eyes
®, a leading first-in-class biologic eye drop made of naturally-occurring cytokines and growth factors, today announced the addition of Dr. Art Epstein to its Clinical Advisory Board.
We are excited to have Dr. Art Epstein join our clinical advisory board. He is a highly respected eye care professional, and will bring valuable insight to our company s efforts, commented C. Randall Harrell, M.D., CEO and Founder of Regener-Eyes
®. We are honored to add Dr. Epstein to our existing board alongside our other impressive members, Dr. Marguerite McDonald, Dr. Eric Donnenfeld, Dr. Paul Karpecki, Dr. Walt Whitley, Dr. Scott Schacter and Dr. Ahmed Fahmy. ....

United States , Scott Schacter , Walt Whitley , Eric Donnenfeld , Ahmed Fahmy , Paul Karpecki , C Randall Harrell , Heidi Hart Pukas , Marguerite Mcdonald , Kostenloser Wertpapierhandel , Ocular Surface Disease Center , Eye Center , American Academy Of Optometry , Clinical Research , Practitioner Of The National Academies Practice , Bart Epstein , Clinical Advisory , Phoenix Eye Care , Dry Eye , Surface Disease Center , Dry Eye Center , Adjunct Associate Professor , Midwestern University Arizona College , American Academy , Distinguished Practitioner , National Academies ,